-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Upgrades Chemours to Outperform, Maintains Price Target to $19

Benzinga·03/27/2025 10:48:19
Listen to the news
Mizuho analyst John Roberts upgrades Chemours (NYSE:CC) from Neutral to Outperform and maintains the price target from $19 to $19.